Interest of Oxytocin as an Adjuvant Treatment of Psycho-educational Measures in Challenging Behaviors in Children With Autism Spectrum Disorders and Moderate to Severe Intellectual Disability: Feasibility and Safety Study.

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Autism Spectrum Disorder

Interventions

DRUG

Oxytocin nasal spray

intranasal oxytocin treatment once a day during 6 weeks

Trial Locations (1)

Toulouse University hospital, Toulouse

All Listed Sponsors

lead

University Hospital, Toulouse

OTHER